Condition: Glioblastoma · Recurrent Disease · Recurrent Glioblastoma · Sponsor: AHS Cancer Control Alberta
This will be a single-arm open-label prospective pilot feasibility trial recruiting 10 adult patients with recurrent glioblastoma who are assigned to receive the personalized study treatment based on the genetic profile of their recurrent GBM tumor resected at the time of surgery. It will be aimed to gather preliminary information on the study intervention and the feasibility of conducting a full-scale trial.
This description comes directly from the study's public registry record.
Paula de Robles, MD · 587-231-6051 · paula.derobles@albertahealthservices.ca
Michelle Kan · michelle.kan@albertahealthservices.ca
Always discuss trial participation with your own doctor first.
| Arthur J.E. Child Comprehensive Cancer Centre | Calgary, Alberta, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05432518